5-Hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors

Immunopharmacology

Volumn 43, Issue 2-3, 1999, Pages 195-201

  Griesbacher, Thomas ^a   Rainer, Irmgard ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

5 Hydroxytryptamine release; Bradykinin agonists; Bradykinin antagonists; FR167344; FR173657; FR190997; Hoe 140; Icatibant; Mast cell degranulation

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 3 BROMO 8 [2,6 DICHLORO 3 [N [4 (N,N DIMETHYLCARBAMOYL)CINNAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYLIMIDAZO[1,2 A]PYRIDINE; 8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYL 4 (2 PYRIDYLMETHOXY)QUINOLINE; BRADYKININ B2 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ RECEPTOR; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; CIMETIDINE; ICATIBANT; MEPYRAMINE; METHYSERGIDE; ONDANSETRON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; EXTRAVASATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; MAST CELL DEGRANULATION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRADYKININ; CELL DEGRANULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MAST CELLS; PYRIDINES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; SEROTONIN; SKIN;

EID: 0032707633     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00103-4     Document Type: Conference Paper

References (26)

1. 2 receptor. Mol. Pharmacol. 52, 16-20.
2. Aramori, I., Zenkoh, J., Morikawa, N., O'Donnell, N., Asano, M., Nakamura, K., Iwami, M., Kojo, H., Notsu, Y., 1997b. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167334 and FR173657. Mol. Pharmacol. 51, 171-176.
3. 2 receptor antagonist, FR173657. Br. J. Pharmacol. 120, 617-624.
4. 2 kinin receptor antagonist, of antigen-induced nasal blockage. Br. J. Pharmacol. 111, 969-971.
5. i-like proteins, a receptor-independent effect of kinins in mast cells. Mol. Pharmacol. 38, 816-822.
6. 2 receptors in bradykinin-induced rat paw oedema. Br. J. Pharmacol. 114, 1005-1013.
7. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol. 117, 793-798.
8. Devillier, P., Drapeau, G., Renoux, M., Regoli, D., 1989. Role of N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides. Eur. J. Pharmacol. 168, 53-60.
9. Griesbacher, T., 1997. Effectivity of the nonpeptide bradykinin antagonist, FR173657, in experimental models of acute pancreatitis and cystitis in rats. Br. J. Pharmacol. 122, 352P.
10. Griesbacher, T., Althuber, P., Zenz, M., Rainer, I., Griengl, S., Lembeck, F., 1998a. Vespula vulgaris venom: role of kinins and release of 5-hydroxytryptamine from skin mast cells. Eur. J. Pharmacol. 351, 95-104.
11. 2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. Br. J. Pharmacol. 124, 1328-1334.
12. Hock, F.J., Wirth, K., Albus, U., Linz, W., Gerhards, H.J., Wiemer, G., Henke, S., Breipohl, G., König, W., Knolle, J., Schölkens, B.A., 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102, 769-773.
13. 2 receptor antagonist, FR167344. Eur. J. Pharmacol. 333, 79-86.
14. Lagunoff, D., Martin, T.W., 1983. Agents that release histamine from mast cells. Annu. Rev. Pharmacol. Toxicol. 23, 331-351.
15. Lawrence, I.D., Warner, J.A., Cohan, V.L., Lichtenstein, L.M., Kagey-Sobotka, A., Vavrek, R.J., Stewart, J.M., Proud, D., 1989. Induction of histamine release from human skin mast cells by bradykinin analogs. Biochem. Pharmacol. 38, 227-233.
16. Lembeck, F., Griesbacher, T., Eckhardt, M., Henke, S., Breipohl, G., Knolle, J., 1991. New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol. 102, 297-304.
17. 2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 121, 723-730.
18. 1 receptors. Br. J. Pharmacol. 117, 1619-1624.
19. Parratt, J.R., West, G.B., 1957. Release of 5-hydroxytryptamine and histamine from tissues of the rat. J. Physiol. 137, 179-192.
20. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110, 1441-1444.
21. 2 receptor antagonists: development and applications. Can. J. Physiol. Pharmacol. 73, 787-790.
22. Viettinghoff, G., Paegelow, I., Reissmann, S., 1996. Induction of histamine release from rat mast cells by bradykinin analogues. Peptides 17, 1467-1470.
23. 2 receptor antagonist, is due to mast cell degranulation. Eur. J. Pharmacol. 161, 143-149.
24. Wirth, K., Hock, F.J., Albus, U., Linz, W., Alpermann, H.G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W., Knolle, J., Schölkens, B.A., 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102, 774-777.
25. Wirth, K.J., Heitsch, H., Schölkens, B.A., 1995. Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol. 73, 797-804.
26. Zar, J.H., 1984. Biostatistical Analysis, 2nd edn. Prentice-Hall, Englewood Cliffs, NJ.